FABP5

FABP5 Molekülinformation

Englischer Name	Fatty acid binding protein 5	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1	Target-Alias	Fatty Acid Binding Protein 5，PA-FABP，E-FABP，Psoriasis-Associated Fatty Acid-Binding Protein Homolog，Fatty Acid Binding Protein 5 (Psoriasis-Associated)，Epidermal-Type Fatty Acid-Binding Protein，Fatty Acid-Binding Protein 5，KFABP，Fatty Acid-Binding Protein， Epidermal，PAFABP，EFABP，FABP5
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

Englischer Name	Fatty acid binding protein 5
Target-Alias	Fatty Acid Binding Protein 5，PA-FABP，E-FABP，Psoriasis-Associated Fatty Acid-Binding Protein Homolog，Fatty Acid Binding Protein 5 (Psoriasis-Associated)，Epidermal-Type Fatty Acid-Binding Protein，Fatty Acid-Binding Protein 5，KFABP，Fatty Acid-Binding Protein， Epidermal，PAFABP，EFABP，FABP5
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	1
Höchste Forschungs- und Entwicklungsphase	Phase 1 Clinical

FABP5 Produktliste

Attribut
Protein (1)
Produktbibliothek
Online (1)
Spezies
Human (1)
Etikett
His Tag (1)
Marker
Unconjugated (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
FA5-H5140	Human	E. coli	Human FABP5 / E-FABP Protein, His Tag				In den Warenkorb legen

Gesamtmenge1

FABP5 Molekülhintergrund

Fatty acid-binding protein 5 (FABP5), is also known as Fatty acid-binding protein, epidermal (E-FABP), Psoriasis-associated fatty acid-binding protein homolog (PA-FABP). FABP5 / E-FABP belongs to the calycin superfamily and fatty-acid binding protein (FABP) family. FABP5 / E-FABP is highly expressed in psoriatic skin. FABP5 / E-FABP has high specificity for fatty acids and has highest affinity for C18 chain length. FABP5 may be involved in keratinocyte differentiation.

FABP5 Molekülalias

FABP5,E-FABP,PA-FABP

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
ART-2612	ART-2612; ART 26.12; ART26.12	Phase 1 Clinical	Stony Brook University, The Research Foundation of the State University of New York	Anxiety; Breast Neoplasms; Neoplasms; Pain; Peripheral Nervous System Diseases; Prostatic Neoplasms	Details